Joaquín Zamarro

Joaquín Zamarro

Auto-generated profile, based on publicly available information

Joaquín Zamarro

Hospital Universitario Virgen de la Arrixaca, Murcia, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Radiology
Verified
Journal Article
Closed access
LMLukas Meyer
Lukas Meyer
GBGabriel Broocks
Gabriel Broocks
MAMaria Alexandrou
Maria Alexandrou
ÁLÁlex Lüttich
Álex Lüttich
JLJosé Ángel Larrea
José Ángel Larrea
CSChristian Paul Stracke
Christian Paul Stracke
For patients with symptomatic acute occlusions of the internal carotid artery below the circle of Willis, endovascular and best medical treatment were both effective and safe therapeutic options.

17 August 2022 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
CPCarlos Piñana
Carlos Piñana
SFSebastian Remollo Friedemann
Sebastian Remollo Friedemann
JZJoaquín Zamarro
Joaquín Zamarro
MWMariano Werner
Mariano Werner
MRMariano Espinosa de Rueda
Mariano Espinosa de Rueda
ATAlejandro Tomasello
Alejandro Tomasello
Background Flow diverters have emerged in recent years as a safe and effective treatment for intracranial aneurysms, with expanding indications. The Derivo embolization device (DED) is a second-generation flow diverter with a surface finish that may reduce thrombogenicity. We report our multicenter experience evaluating its safety and efficacy. Methods We retrospectively analyzed all patients treated with the DED in eight centers in Spain between 2016 and 2020. Demographics, clinical data, procedural complications, morbidity and aneurysm occlusion rates were collected. Results A total of 209 patients with 250 aneurysms were treated (77.5% women). The majority of aneurysms were located in the internal carotid artery (86.8%) and most (69.2%) were small (<10 mm) with a median maximum diameter of 5.85 mm and median neck size of 4 mm. DED deployment was successful in all cases, despite two malfunctioning devices (1%). Major complications occurred in nine patients (4.3%), while mild neurologic clinical events were registered in 23 (11%); four patients died (1.9%). A total of 194 aneurysms had an angiographic follow-up at 6 months and showed complete aneurysm occlusion in 75% of cases. Twelve-month follow-up was available for 112 of the treated aneurysms, with a total occlusion rate of 83%. Conclusion The DED is a second-generation surface-modified flow diverter that presents an option for treatment of intracranial aneurysms with comparable safety and efficacy to other available flow diverter devices. Nonetheless, risks are not negligible, and must be balanced against the natural history risk of cerebral aneurysms, considering the tendency to widen indications for treatment of smaller and less complex lesions in day-to-day use.

11 August 2016 in BMC Neurology
Verified
Journal Article
Open access
PDF file
ÁSÁlvaro Sánchez-Larsen
Álvaro Sánchez-Larsen
Tomás SeguraTomás Segura
Tomás Segura
SGSusana García-Muñozguren
Susana García-Muñozguren
JPJavier Peinado-Ródenas
Javier Peinado-Ródenas
JZJoaquín Zamarro
Joaquín Zamarro
FHFrancisco Hernández-Fernández
Francisco Hernández-Fernández
Magnesium has a regulatory role in the excitability of cell membranes, and is also a cofactor in the phosphorylation of thiamine. Hypomagnesemia has been associated with coronary vasospasm, but its role in cerebrovascular pathology is controversial, and cerebral vasospasm exclusively attributable to hypomagnesemia has not been reported in humans. We report the case of a 51-year-old man in whom uncontrollable vomiting, treatment with omeprazole and thiazide, and renal impairment lead to a severe hypomagnesemia (magnesium below the level of detection in blood tests), which secondarily caused Wernicke’s encephalopathy and vasospasm in multiple cerebral arteries (seen with cerebral angiography and CT angiography) that presented with a complete right hemisphere neurological deficit. These disturbances completely resolved when magnesium levels were normalized and subsequent neuroimaging tests confirmed the resolution of angiographic changes. Our case suggests that hypomagnesemia should be considered in the differential diagnosis of patients with neurological symptoms and predisposing causes.

1 April 2022 in Stroke
Verified
Journal Article
Open access
PDF file
MRManuel Requena
Manuel Requena
MRMarc Ribó
Marc Ribó
JZJoaquin Zamarro
Joaquin Zamarro
PVPedro Vega
Pedro Vega
JBJordi Blasco
Jordi Blasco
ATAlejandro Tomasello
Alejandro Tomasello
Background: The Advanced Neurovascular Access (ANA) thrombectomy system is a novel stroke thrombectomy device comprising a self-expanding funnel designed to reduce clot fragmentation by locally restricting flow while becoming as wide as the lodging artery. Once deployed, the ANA device allows distal aspiration combined with a stent retriever to mobilize the clot into the funnel where it remains copped during extraction. We investigated the safety and efficacy of ANA catheter system. Methods: SOLONDA (Solitaire in Combination With the ANA Catheter System as Manufactured by Anaconda) was a prospective, open, single-arm, multicenter trial with blinded assessment of the primary outcome by an independent core lab. Patients with anterior circulation vessel occlusion admitted within 8 hours from symptom onset were eligible. The primary end point was successful reperfusion (modified Thrombolysis in Cerebral Infarction score 2b–3) with ≤3 passes of the ANA device in combination with stent retriever, before the use of rescue therapy in the intention to treat population. Primary predefined analysis was noninferiority as compared to the performance end point observed in HERMES (High Effective Reperfusion Using Multiple Endovascular Devices). Results: After enrollment of 74 patients, an interim analysis was conducted, and the trial Steering Committee decided to terminate recruitment due to safety and performance objectives were reached. Mean age was 71.6 (SD 8.9) years, 46.6% women and median National Institutes of Health Stroke Scale on admission 14 (interquartile range, 10–19). Successful reperfusion within 3 passes before rescue therapy was achieved in 60/72 (83.3% [95% CI, 74.7%–91.9%]) with a rate of complete reperfusion (modified Thrombolysis in Cerebral Infarction score 2c–3) of 60% (95% CI, 48.4%–71.1%; 43/72 patients). After noninferiority was confirmed ( P <0.01), the ANA device also showed superiority in the rate of successful reperfusion with ≤3 passes ( P =0.02). First-pass successful recanalization rate was 55.6% (95% CI, 44.1%–67.0%), with a first-pass complete recanalization rate of 38.9% (95% CI, 27.6%–50.1%). Rescue therapy to obtain a modified Thrombolysis in Cerebral Infarction score 2b–3 was needed in 12/72 (17%) patients. At 90 days, the rate of favorable functional outcome (modified Rankin Scale score 0–2) was 57.5% (95% CI, 46.2%–68.9%), and the rate of excellent functional outcome (modified Rankin Scale score 0–1) was 45.2% (95% CI, 33.8%–56.6%). The rate of severe adverse device related was 1.4%. Conclusions: In this clinical experience, the ANA device achieved a high rate of complete recanalization with a preliminary good safety profile and favorable 90 days clinical outcomes. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04095767.

17 September 2024 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
CPCarlos Pérez-García
Carlos Pérez-García
MCMiguel Castaño
Miguel Castaño
JLJuan Carlos Llibre
Juan Carlos Llibre
LVLuis Vargas
Luis Vargas
ALAlfonso Lopez-Frias
Alfonso Lopez-Frias
MMManuel Moreu
Manuel Moreu
Background Efficient recanalization of occluded cerebral arteries is crucial in the treatment of acute ischemic stroke. Double stent retrievers have shown the potential to enhance the rates of recanalization on the first pass. This study aims to evaluate the efficacy and safety of the double stent retriever technique and the predictors of achieving first-pass effect in patients with acute ischemic stroke. Methods This prospective multicenter study involved 209 patients from 16 comprehensive stroke centers in Spain. Patients with occlusions in the anterior circulation were treated using the Aperio Hybrid double stent retriever. The study examined various deployment techniques, including simultaneous and sequential deployment and stent configurations, comparing the Y-shaped and parallel configurations. Results The double stent retriever technique achieved a first-pass effect in 72.7% of cases and a final successful recanalization rate of 99.5%. The Y-shaped configuration was significantly associated with higher recanalization rates on the first pass (OR 2.59, 95% CI 1.18 to 5.68, P=0.02). Procedural complications were mild to moderate in 6.7% and severe in 1.5% of cases, with symptomatic intracranial hemorrhage occurring in 3.3% of patients. At 3 months follow-up, 57.2% of patients achieved a good clinical outcome, with a mortality rate of 15.1%. Conclusion The findings support the efficacy of the double stent retriever technique, particularly the Y-shaped configuration, in achieving high recanalization rates on the first pass with an acceptable safety profile. This technique may offer clinical benefits for future acute ischemic stroke treatment protocols.

26 February 2026 in American Journal of Transplantation
Verified
Journal Article
Closed access
MRMario Royo-Villanova
Mario Royo-Villanova
BDBeatriz Domínguez-Gil
Beatriz Domínguez-Gil
JMJosé Moya
José Moya
MBMaría A. Ballesteros
María A. Ballesteros
AOAlejandro Ortín
Alejandro Ortín
EMEduardo Miñambres
Eduardo Miñambres